Adam Rosenthal
FounderFounder & CEO at Star Therapeutics · Co-founder and former CEO; Director at Electra Therapeutics
San Francisco Bay Area
Find your path to Adam
97 people in our graph share verified history with Adam — schools, employers, funds. One of them is your warm intro.
About
Adam Rosenthal is the CEO and Founder of Star Therapeutics, where he has led the invention and development of molecules including Enjaymo, an approved treatment for cold agglutinin disease, and several candidates in Phase 3 trials such as VGA039 for von Willebrand disease, ELA026 for secondary HLH, and Riliprubart for CIDP. His work is also associated with three acquisitions: Vega Therapeutics in a $2 billion deal at Phase 3, True North Therapeutics in an $825 million deal at Phase 1/2, and iPierian in a $725 million preclinical-stage deal.
Founder & CEO at Star Therapeutics
Intro paths
In turn, Adam can intro founders to Star Therapeutics's investors below.
Star Therapeutics's investors · 15
Co-founders at Star Therapeutics
Co-founder and former CEO; Director at Electra Therapeutics
Intro paths
In turn, Adam can intro founders to Electra Therapeutics's investors below.
Experience
- Star TherapeuticsCEO and Foundercurrent2018 — present
- Vega TherapeuticsCEO and Co-Founder2018 — 2026
- Electra TherapeuticsCEO and Co-Founder2018 — 2023
- True North TherapeuticsChief Business Officer2013 — 2017
- iPierianVP, Head of Corporate Development2010 — 2014
- The Boston Consulting GroupProject Leader2007 — 2010
Frequently asked questions
- Who is Adam Rosenthal?
- Adam Rosenthal is the CEO and Founder of Star Therapeutics, where he has led the invention and development of molecules including Enjaymo, an approved treatment for cold agglutinin disease, and several candidates in Phase 3 trials such as VGA039 for von Willebrand disease, ELA026 for secondary HLH, and Riliprubart for CIDP. His work is also associated with three acquisitions: Vega Therapeutics in a $2 billion deal at Phase 3, True North Therapeutics in an $825 million deal at Phase 1/2, and iPierian in a $725 million preclinical-stage deal.
- Where does Adam Rosenthal work?
- Adam Rosenthal is Co-founder and former CEO; Director of Electra Therapeutics and Founder & CEO at Star Therapeutics.
- What companies did Adam Rosenthal found?
- Adam Rosenthal founded Electra Therapeutics, Star Therapeutics.
- Where did Adam Rosenthal go to school?
- Adam Rosenthal studied at Massachusetts Institute of Technology / Harvard Medical School (PhD, Biomedical Engineering); Massachusetts Institute of Technology (MEng, Electrical Engineering & Computer Science); Massachusetts Institute of Technology (BS, Electrical Engineering; Brain and Cognitive Science).
Founder mafias
Massachusetts Institute of Technology mafia1,221
Also came through, then founded or led a company.
+ 1,214 more
The Boston Consulting Group mafia83
Also came through, then founded or led a company.
+ 76 more
Same school
Also attended Massachusetts Institute of Technology2,000
+ 1,994 more
Shared employers
Also worked at Star Therapeutics1
Also worked at Electra Therapeutics1
Also worked at iPierian3
Also worked at The Boston Consulting Group1,379
+ 1,373 more